查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1948821

DNA扩增试剂盒市场－全球产业规模、份额、趋势、机会及按类型、应用、地区和竞争格局分類的预测（2021-2031年）

DNA Amplification Kit Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type ( PCR, Isothermal Amplification), By Application (Clinical, Research), By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球DNA扩增试剂盒市场预计将从2025年的11.5031亿美元成长到2031年的16.7563亿美元，复合年增长率为6.47%。

这些试剂盒包含用于目标核酸序列指数级复製的专用酵素混合物和试剂组，在临床诊断和生命科学研究中发挥至关重要的作用。市场成长的根本驱动力是感染疾病日益普遍以及分子诊断在个人化癌症治疗中日益广泛的应用。这些持续的驱动因素确保了长期需求，而非供应链转移和短期监管变化等暂时性的产业波动。

市场概览
预测期 2027-2031
市场规模：2025年 11.5031亿美元
市场规模：2031年 16.7563亿美元
复合年增长率：2026-2031年 6.47%
成长最快的细分市场 PCR
最大的市场 北美洲

儘管前景乐观，但先进扩增设备所需的大量资本投入，对资源匮乏地区的市场成长构成重大障碍。这一经济壁垒限制了发展中地区的市场准入，阻碍了自动化解决方案的广泛应用。 MedTech Europe 预测，到 2024 年，欧洲医疗技术市场规模将达到 1,700 亿欧元，其中体外诊断将成为最大的细分市场，这体现了该行业的经济规模。该数据也印证了诊断产业的经济规模，而 DNA 扩增产品在该产业中发挥关键作用。

市场驱动因素

遗传性疾病和感染疾病率的上升是全球DNA扩增试剂盒市场的主要驱动力，持续推动对分子诊断工具的需求。随着结核病和呼吸道病毒等病原体带来的全球健康挑战不断加剧，人们对聚合酵素链锁反应（PCR）等精准检测方法的依赖性显着增强。这种依赖性也体现在主要诊断设备製造商的财务表现中，这些製造商提供必要的试剂和酵素。例如，凯杰公司在2025年2月发布的「2024年第四季及全年财务表现」报告中指出，其诊断解决方案，特别是QIAstat-Dx和QuantiFERON产品线，实现了两位数的成长，凸显了可靠检测基础设施的紧迫性。

同时，生物技术和製药业的强劲研发扩张推动了药物发现和基因测序所需扩增试剂盒的消费。生物製药公司正投入大量资金开发标靶治疗，而这需要大量的耗材用于检验和基因分析。罗氏公司2025年1月发布的「2024年报告」显示，其研发支出达到130亿瑞士法郎，并印证了这项财务投入。这种研发主导的环境确保了製造商稳定的收入来源。 Illumina公司2025年2月发布的「10-K表格」报告显示，其核心耗材销售额达31.7亿美元，这充分体现了试剂类产品在基因组学生态系统中的巨大价值。

市场挑战

先进扩增设备所需的大量资本投入是全球DNA扩增试剂盒市场成长的主要障碍。虽然试剂盒本身是持续消耗的耗材，但其有效利用完全依赖昂贵的自动化处理平台和聚合酵素连锁反应热迴圈仪。在资源匮乏的环境中，无力资金筹措这部分初始基础建设费用会造成瓶颈，阻碍后续试剂的购买。因此，製造商无法触及发展中地区的大部分潜在客户，这限制了试剂盒的总销量，儘管这些地区对诊断有着迫切的临床需求。

产业内不断上涨的营运成本加剧了这种财务压力，阻碍了设备价格的大幅下降。根据 MedTech Europe 于 2025 年发布的调查数据，体外诊断试剂製造商在五年周期内，其再认证和监管维护支出将增加 70%。如此显着的营运成本成长限制了製造商降低新检查室进入门槛的柔软性。因此，进入门槛依然很高，直接限制了 DNA 扩增技术的广泛应用。

市场趋势

製造商正在加速开发微型化的「晶片实验室」系统，该系统将DNA扩增化学与微流体技术结合。这项创新能够精确处理微量样本，显着降低试剂成本，同时在单一携带式试剂盒内实现高通量并行处理。这些紧凑、快速反应的设备在分散式医疗环境中具有特别显着的市场影响力，因为在这些环境中，速度至关重要。例如，生物梅里埃公司在2025年9月发布的「2025年上半年财务表现」报告中指出，其照护现场分子诊断解决方案SPOTFIRE系统的销售额达到7,900万欧元，内部成长143%。

另一项重要进展是多重扩增试剂盒的广泛应用，该试剂盒可在单次反应中检测和扩增多个DNA标靶。这项技术能够同时识别多种遗传标记和病原体，从而简化法医分析和感染疾病诊断的工作流程，节省耗材和时间。丹纳赫公司于2025年10月发布的2025年第三季财务报告显示，市场对这些多标靶检测的需求强劲。该公司子公司Sepede报告称，其核心非呼吸道检测项目实现了强劲的个位数成长，这主要得益于性健康多重检测收入约20%的成长。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球DNA扩增试剂盒市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 按类型（PCR、等温扩增）
    • 依用途（临床用途、研究用途）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章 北美DNA扩增试剂盒市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国家分析
    • 我们
    • 加拿大
    • 墨西哥

7. 欧洲DNA扩增试剂盒市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国家分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

8. 亚太地区DNA扩增试剂盒市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

9. 中东与非洲DNA扩增试剂盒市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东和非洲：国家分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲DNA扩增试剂盒市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国家分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 司机
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 最新进展

第十三章 全球DNA扩增试剂盒市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的可能性
  • 供应商电力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Cytiva lifesciences
  • Thermo Fisher Scientific Inc.
  • Sigma-Aldrich Solutions
  • QIAGEN NV
  • Jiangsu Cowin Biotech Co Ltd

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 19789

The Global DNA Amplification Kit Market is projected to expand from USD 1,150.31 Million in 2025 to USD 1,675.63 Million by 2031, registering a CAGR of 6.47%. These kits comprise specialized enzyme mixtures and reagent sets essential for the exponential replication of target nucleic acid sequences, serving critical roles in clinical diagnostics and life science research. The market's growth is fundamentally anchored by the increasing prevalence of infectious diseases and the growing incorporation of molecular diagnostics into personalized oncology treatments. These enduring drivers ensure sustained long-term demand, distinguishing them from temporary industry fluctuations such as supply chain shifts or short-term regulatory changes.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 1,150.31 Million
Market Size 2031USD 1,675.63 Million
CAGR 2026-20316.47%
Fastest Growing SegmentPCR
Largest MarketNorth America

Despite this positive outlook, the substantial capital investment required for advanced amplification instrumentation poses a major hurdle to market growth in resource-constrained environments. This financial barrier restricts accessibility in developing regions and hinders the broad adoption of automated solutions. Highlighting the economic magnitude of the sector, MedTech Europe estimated the 2024 European medical technology market at 170 billion euros, with in vitro diagnostics emerging as the largest segment. This data underscores the significant economic scale of the diagnostic landscape in which DNA amplification products operate.

Market Driver

The rising incidence of genetic disorders and infectious diseases acts as a primary engine for the Global DNA Amplification Kit Market, generating continuous demand for molecular diagnostic tools. As global health continues to face challenges from pathogens like tuberculosis and respiratory viruses, the dependence on precise detection methods such as polymerase chain reaction (PCR) assays has grown significantly. This reliance is reflected in the financial results of major diagnostic providers supplying necessary reagents and enzymes; for instance, Qiagen reported in their February 2025 'Fourth Quarter and Full-Year 2024 Results' that their diagnostic solutions, specifically the QIAstat-Dx and QuantiFERON portfolios, achieved double-digit growth, highlighting the urgent requirement for reliable testing infrastructure.

Concurrently, the vigorous expansion of research and development within the biotechnology and pharmaceutical sectors is boosting the consumption of amplification kits used in drug discovery and genomic sequencing. Biopharmaceutical firms are allocating massive investments toward developing targeted therapies, a process necessitating large quantities of consumables for validation and genetic analysis. Underscoring this financial commitment, Roche's January 2025 'Annual Report 2024' noted R&D expenses of 13.0 billion CHF. This research-heavy landscape guarantees a steady revenue stream for manufacturers, as evidenced by Illumina's February 2025 'Form 10-K', which reported core consumables revenue of $3.17 billion, demonstrating the immense value of reagent-based products in the genomic ecosystem.

Market Challenge

The substantial capital investment needed for advanced amplification instruments serves as a major obstacle to the growth of the Global DNA Amplification Kit Market. Although the kits are recurring consumables, their effective use relies entirely on the presence of costly automated processing platforms and thermal cyclers. In settings with limited resources, the inability to finance this initial infrastructure creates a bottleneck that precludes the subsequent procurement of reagents. As a result, manufacturers are unable to reach a significant segment of potential customers in developing regions, which effectively limits the total volume of kit sales despite the urgent clinical demand for diagnostics in those areas.

This financial pressure is exacerbated by increasing operational costs within the sector, which hinder the ability to significantly reduce equipment prices. Survey data released by MedTech Europe in 2025 indicates that in vitro diagnostic manufacturers are contending with a 70% rise in spending on re-certification and regulatory maintenance over a five-year cycle. Such a marked increase in overhead expenses restricts manufacturers' flexibility to lower entry costs for new laboratories. Consequently, the high barrier to entry remains in place, directly constraining the broader adoption of DNA amplification technologies.

Market Trends

Manufacturers are increasingly combining DNA amplification chemistries with microfluidic technologies to develop miniaturized "Lab-on-a-Chip" systems. This innovation permits the precise handling of tiny sample volumes, which significantly lowers reagent costs while facilitating high-throughput parallel processing in a single, portable kit. The market impact of these compact, rapid-response devices is evident in decentralized healthcare settings where speed is paramount; for example, bioMerieux reported in their September 2025 'First-Half 2025 Financial Results' that sales of the SPOTFIRE system, a point-of-care molecular solution, reached €79 million, representing a 143% organic increase over the prior year.

Another significant advancement is the widespread adoption of multiplex amplification kits, which are designed to detect and amplify multiple DNA targets within a single reaction. This capability streamlines workflows in forensic analysis and infectious disease diagnostics by enabling the simultaneous identification of various genetic markers or pathogens, thereby conserving both consumables and time. The strong market demand for these multi-target assays is highlighted by Danaher Corporation's October 2025 'Q3 2025 Financial Results', where its subsidiary Cepheid noted high single-digit growth in its core non-respiratory menu, driven by an approximate 20% rise in sexual health multiplex testing revenue.

Key Market Players

  • Cytiva lifesciences
  • Thermo Fisher Scientific Inc.
  • Sigma-Aldrich Solutions
  • QIAGEN NV
  • Jiangsu Cowin Biotech Co Ltd

Report Scope

In this report, the Global DNA Amplification Kit Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

DNA Amplification Kit Market, By Type

  • PCR
  • Isothermal Amplification

DNA Amplification Kit Market, By Application

  • Clinical
  • Research

DNA Amplification Kit Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global DNA Amplification Kit Market.

Available Customizations:

Global DNA Amplification Kit Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global DNA Amplification Kit Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (PCR, Isothermal Amplification)
    • 5.2.2. By Application (Clinical, Research)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America DNA Amplification Kit Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States DNA Amplification Kit Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada DNA Amplification Kit Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico DNA Amplification Kit Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application

7. Europe DNA Amplification Kit Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany DNA Amplification Kit Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
    • 7.3.2. France DNA Amplification Kit Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom DNA Amplification Kit Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy DNA Amplification Kit Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain DNA Amplification Kit Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application

8. Asia Pacific DNA Amplification Kit Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China DNA Amplification Kit Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India DNA Amplification Kit Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan DNA Amplification Kit Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea DNA Amplification Kit Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia DNA Amplification Kit Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application

9. Middle East & Africa DNA Amplification Kit Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia DNA Amplification Kit Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE DNA Amplification Kit Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa DNA Amplification Kit Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application

10. South America DNA Amplification Kit Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil DNA Amplification Kit Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia DNA Amplification Kit Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina DNA Amplification Kit Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global DNA Amplification Kit Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Cytiva lifesciences
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Thermo Fisher Scientific Inc.
  • 15.3. Sigma-Aldrich Solutions
  • 15.4. QIAGEN NV
  • 15.5. Jiangsu Cowin Biotech Co Ltd

16. Strategic Recommendations

17. About Us & Disclaimer